Release Date: 16/08/11 12:38 Summary: Ceasing to be a substantial holder Price Sensitive: No Download Document 364.14KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%